Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS: Acute spinal cord injury, part I: pathophysiologic mechanisms.
Clin Neuropharmacol 2001, 24:254–264.
Tator CH: Experimental and clinical studies of the pathophysiology and management of acute spinal cord injury.
J Spinal Cord Med 1996, 19:206–214.
Fitch MT, Doller C, Combs CK, Landreth GE, Silver J: Cellular and molecular mechanisms of glial scarring and progressive cavitation: In vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma.
J Neurosci 1999, 19:8182–8198.
Faden AI: Experimental neurobiology of central nervous system trauma.
Crit Rev Neurobiol 1993, 7:175–186.
Silver J, Miller JH: Regeneration beyond the glial scar.
Nat Rev Neurosci 2004, 5:146–156.
Sekhon LH, Fehlings MG: Epidemiology, demographics, and pathophysiology of acute spinal cord injury.
Spine 2001, 26:S2-S12.
Tator CH: Strategies for recovery and regeneration after brain and spinal cord injury.
Inj Prev 2002,8(Suppl 4):IV33–36.
Hagg T, Oudega M: Degenerative and spontaneous regenerative processes after spinal cord injury.
J Neurotrauma 2006, 23:264–280.
Yiu G, He Z: Glial inhibition of CNS axon regeneration.
Nat Rev Neurosci 2006, 7:617–627.
Laabs TL, Wang H, Katagiri Y, McCann T, Fawcett JW, Geller HM: Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans.
J Neurosci 2007, 27:14494–14501.
Dusart I, Schwab ME: Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord.
Eur J Neurosci 1994, 6:712–724.
Beattie MS: Inflammation and apoptosis: linked therapeutic targets in spinal cord injury.
Trends Mol Med 2004, 10:580–583.
Spranger M, Fontana A: Activation of microglia: a dangerous interlude in immune function in the brain.
The Neuroscientist 1996, 2:293–305.
Smith ME, van der Maesen K, Somera FP: Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production.
J Neurosci Res 1998, 54:68–78.
Nagamoto-Combs K, Morecraft RJ, Darling WG, Combs CK: Long-term gliosis and molecular changes in the cervical spinal cord of the rhesus monkey after traumatic brain injury.
J Neurotrauma 2010, 27:565–585.
Byrnes KR, Garay J, Di Giovanni S, De Biase A, Knoblach SM, Hoffman EP, Movesyan V, Faden AI: Expression of two temporally distinct microglia-related gene clusters after spinal cord injury.
Glia 2006, 53:420–433.
Byrnes KR, Washington PM, Knoblach SM, Hoffman E, Faden AI: Delayed inflammatory mRNA and protein expression after spinal cord injury.
J Neuroinflammation 2011, 8:130–144.
Cross AR, Segal AW: The NADPH oxidase of professional phagocytes–prototype of the NOX electron transport chain systems.
Biochim Biophys Acta 2004, 1657:1–22.
Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS: NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.
J Biol Chem 2004, 279:1415–1421.
Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.
Nat Rev Neurosci 2007, 8:57–69.
Aldskogius H, Kozlova EN: Central neuron-glial and glial-glial interactions following axon injury.
Prog Neurobiol 1998, 55:1–26.
Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, Faden AI: Gene profiling in spinal cord injury shows role of cell cycle in neuronal death.
Ann Neurol 2003, 53:4544–4568.
Byrnes KR, Stoica BA, Fricke S, Di Giovanni S, Faden AI: Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury.
Brain 2007, 130:2977–2992.
Wu J, Stoica BA, Dinizo M, Pajoohesh-Ganji A, Piao C, Faden AI: Delayed cell cycle pathway modulation facilitates recovery after spinal cord injury.
Cell Cycle 2012, 11:1782–1795.
Wu J, Stoica BA, Faden AI: Cell cycle activation and spinal cord injury.
Neurotherapeutics 2011, 8:221–228.
Tian DS, Yu ZY, Xie MJ, Bu BT, Witte OW, Wang W: Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine.
J Neurosci Res 2006, 84:1053–1063.
Tian DS, Xie MJ, Yu ZY, Zhang Q, Wang YH, Chen B, Chen C, Wang W: Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats.
Brain Res 2007, 1135:177–1785.
Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, Faden AI: Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.
Proc Natl Acad Sci USA 2005, 202:8333–8338.
Hilton GD, Stoica BA, Byrnes KR, Faden AI: Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
J Cereb Blood Flow Metab 2008, 28:1845–1859.
Kabadi SV, Stoica BA, Byrnes KA, Hanscom M, Loane DJ, Faden AI: Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.
J Cereb Blood Flow Metab 2012, 32:137–149.
Zhu Z, Zhang Q, Yu Z, Zhang L, Tian D, Zhu S, Bu B, Xie M, Wang W: Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo.
Glia 2007, 55:546–558.
Wang W, Redecker C, Yu ZY, Xie MJ, Tian D, Zhang L, Bu BT, Witte OW: Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition.
J Clin Neurosci 2008, 15:278–285.
Zhang Q, Chen C, Lu J, Xie M, Pan D, Luo X, Yu Z, Dong Q, Wang W: Cell cycle inhibition attenuates microglial proliferation and production of IL-1, MIP-1, and NO after focal cerebral ischemia in the rat.
Glia 2009, 57:908–920.
Cernak I, Stoica B, Byrnes KR, Di Giovanni S, Faden AI: Role of the cell cycle in the pathobiology of central nervous system trauma.
Cell Cycle 2005, 4:1286–1293.
Meijer L, Borgne A, Mulner O, Chong JPJ, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Eur J Biochem 1997, 243:527–536.
Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L: CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.
Oncogene 2008, 27:5797–5807.
Yakovlev AG, Faden AI: Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury.
Mol Chem Neuropathol 1994, 23:179–190.
Wu J, Leung PY, Sharp A, Lee HJ, Wrathall JR: Increased expression of the close homolog of the adhesion molecule L1 in different cell types over time after rat spinal cord contusion.
J Neurosci Res 2011, 89:628–638.
Jakovcevski I, Wu J, Karl N, Leshchyns'ka I, Sytnyk V, Chen J, Irintchev A, Schachner M: Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury.
J Neurosci 2007, 27:7222–7233.
Grossman SD, Rosenberg LJ, Wrathall JR: Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion.
Exp Neurol 2001, 168:273–282.
Basso DM, Beattie MS, Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats.
J Neurotrauma 1995, 12:1–21.
Gale K, Kerasidis H, Wrathall JR: Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment.
Exp Neurol 1995, 88:123–134.
Kato H, Takahashi A, Itoyama Y: Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat.
Brain Res Bull 2003, 60:215–221.
Ridet JL, Malhotra SK, Privat A, Gage FH: Reactive astrocytes: Cellular and molecular cues to biological function.
Trends Neurosci 1997, 20:570–577.
Naphade SB, Kigerl KA, Jakeman LB, Kostyk SK, Popovich PG, Kuret J: Progranulin expression is upregulated after spinal contusion in mice.
Acta Neuropathol 2010, 119:123–133.
Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ: Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.
Brain 2010,133(Pt 2):433–447.
Loane DJ, Byrnes KR: Role of microglia in neurotrauma.
Neurotherapeutics 2010, 7:366–377.
Lynch MA: The multifaceted profile of activated microglia.
Mol Neurobiol 2009, 40:139–156.
Kabadi SV, Stoica BA, Loane DJ, Byrnes KR, Hanscom M, Cabatbat RM, Tan MT, Faden AI: Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury.
J Neurotrauma 2012, 29:813–827.
Wang H, Lynch JR, Song P, Yang HJ, Yates RB, Mace B, Warner DS, Guyton JR, Laskowitz DT: Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
Exp Neurol 2007, 206:59–69.
Block ML, Hong JS: Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.
Prog Neurobiol 2005, 76:77–98.
Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, Williams A: Neuroinflammation in Alzheimer's disease and prion disease.
Glia 2002, 40:232–239.
Durand B, Gao FB, Raff M: Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation.
EMBO J 1997, 16:306–317.
Tokumoto YM, Apperly JA, Gao FB, Raff MC: Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation.
Dev Biol 2002, 245:224–234.
Totoiu MO, Keirstead HS: Spinal cord injury is accompanied by chronic progressive demyelination.
J Comp Neurol 2005, 486:373–383.
Atanasoski S, Boentert M, De Ventura L, Pohl H, Baranek C, Beier K, Young P, Barbacid M, Suter U: Postnatal Schwann cell proliferation but not myelination is strictly and uniquely dependent on cyclin-dependent kinase 4 (cdk4).
Mol Cell Neurosci 2008, 37:519–527.
Bettayeb K, Baunbaek D, Delehouze C, Loaec N, Hole AJ, Baumli S, Endicott JA, Douc-Rasy S, Bénard J, Oumata N, Galons H, Meijer L: CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells.
Genes Cancer 2010, 1:369–380.
Kabadi SV, Stoica BS, Hanscom M, Loane DJ, Kharebava G, Murray MG, Cabatbat RM, Faden AI: CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury.
Neurotherapeutics 2012, 9:405–421.